Latest filing published 03 Dec 2014 for IMMUNE PHARMACEUTICALS INC, €16k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ana Stancic: trading record in brief
Ana Stancic discloses dealings in 4 companies, chiefly Viskase Holdings, Inc., Immune Pharmaceuticals Inc and KV Pharmaceutical Co /DE/. Over a trading history stretching from 1 October 2007 to 26 November 2014, the count stands at 7 filings.
On the market, this insider has only ever bought: 1 purchase, €16k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 share grants. In 2014 alone, the filings show 1 purchase and no sales.
The record was last updated on 3 December 2014 with an open-market purchase (€16k) in Immune Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ana Stancic
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares@ US$2.50Common StockSEC:0001144204-14-072161:0Canonical exit: 24 Feb 2015 (T+90)
- 45,000 shares0Common StockSEC:0000930413-12-000226:0
- 45,000 shares0Common StockSEC:0000930413-12-000226:1
- 45,000 shares0Common StockSEC:0000930413-11-007514:0
- 25,000 shares0Common StockSEC:0000930413-11-004317:0
- 7,500 shares0Class A Common StockSEC:0001140361-10-029081:0
- 8,000 shares0Common Stock, par value $0.01 per shareSEC:0001209191-07-056072:0
7 of 7 declarations